Our Digital Pathology DxBook captures in-depth insights on digital pathology utilization across U.S. and EU labs, including scanner and IMS usage, algorithm integration, slide digitization practices, and associated decision-making, operational, and current reimbursement dynamics.
The Digital Pathology DxBook provides insights into current digital pathology utilization and workflows across key oncology-focused customer segments in ~400 U.S. and EU laboratories. The dataset includes:
· Lab Demographics: Institution name, type, country, and other basic identifiers
· Infrastructure: Details on auto-stainers, slide scanners, primary slide viewers/IMS, image analysis software/algorithms, and planned adoption or discontinuation of digital pathology tools
· Send-out Practices: Total test send-out volumes and destination labs
· Future Adoption Plans: Expected uptake of digital pathology tools, projected volume trends, and key adoption drivers
· Decision-Making Insights: Information on lab budgets and key decision-makers
The Digital Pathology DxBook can provide value across sales, marketing, strategy, and product development teams.
